CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in GMAB — Genmab A/S

CIK 884546 SAN FRANCISCO, CA

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,821,763

+$399,034 QoQ

Shares Held

139,125

+9.1% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 292 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. GMAB ranks #158 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,821,763	139,125	+9.1%	Shares	Sole	2026-08-14
2026-03-31	$3,422,729	127,571	+15.1%	Shares	Sole	2026-05-15
2025-12-31	$3,412,609	110,799	+9.5%	Shares	Sole	2026-02-13
2025-09-30	$3,103,159	101,179	+32.3%	Shares	Sole	2025-11-10
2025-06-30	$1,580,304	76,491	+59.8%	Shares	Sole	2025-08-12
2025-03-31	$937,372	47,874	-21.7%	Shares	Sole	2025-09-15
2024-12-31	$1,276,763	61,177	+134.4%	Shares	Sole	2025-02-06
2024-09-30	$636,415	26,104	+94.1%	Shares	Sole	2024-11-12
2024-06-30	$337,998	13,450	-50.7%	Shares	Sole	2024-08-12
2024-03-31	$815,944	27,280	+58.4%	Shares	Sole	2024-05-09
2023-12-31	$548,444	17,225	-6.1%	Shares	Sole	2024-02-06
2023-09-30	$646,851	18,340	+146.2%	Shares	Sole	2023-11-08
2023-06-30	$283,136	7,449	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.